Mycotic keratitis: susceptibility to antiseptic agents

M J Martin1, M R Rahman, G J Johnson

  • 1International Centre for Eye Health, Institute of Ophthalmology, Bath St., London, UK.

Insights

Oculomycosis treatment is challenging in developing nations. Chlorhexidine demonstrated efficacy against fungal keratitis in a pilot study, suggesting its potential as an accessible first-line antifungal agent.

Area of Science:

  • Ophthalmology
  • Mycology
  • Infectious Diseases

Background:

  • Oculomycosis presents a significant health challenge, particularly in developing countries due to limited access and high costs of specific antifungal medications.
  • Antiseptic agents offer a potential alternative for treating fungal eye infections when standard antifungals are unavailable.

Purpose of the Study:

  • To investigate the in vitro and in vivo efficacy of antiseptic agents as alternatives for treating oculomycosis.
  • To evaluate chlorhexidine, povidone iodine, propamidine, and polyhexamethylenebiguanide against fungal isolates and compare their effectiveness with econazole.

Main Methods:

  • Fungal isolates from Indian and Ghanaian patients were tested against antiseptics and econazole using an in vitro agar diffusion method.
  • A pilot clinical study in India assessed the efficacy of chlorhexidine and econazole in treating fungal corneal ulcers.

Main Results:

  • In vitro, chlorhexidine exhibited a dose-dependent response, povidone iodine was effective at all concentrations, and econazole showed the highest efficacy.
  • Clinically, both chlorhexidine and econazole were effective for fungal corneal ulcers, whereas povidone iodine was ineffective.

Conclusions:

  • Chlorhexidine demonstrates promising efficacy for fungal keratitis, particularly in resource-limited settings.
  • Chlorhexidine may serve as a valuable and accessible first-line treatment option for fungal keratitis when specific antifungals are not readily available.

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...